View a ticker or compare two or three
ORGS
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I. Advisor
published Earnings

ORGS is expected to report earnings to fall 148.28% to 14 cents per share on August 13

Orgenesis ORGS Stock Earnings Reports
Q2'24
Est.
$0.14
Q1'24
Missed
by $0.33
Q4'23
Missed
by $1.34
Q3'23
Beat
by $0.33
Q2'23
Missed
by $0.21
The last earnings report on May 21 showed earnings per share of -28 cents, missing the estimate of 3 cents. With 22.03K shares outstanding, the current market capitalization sits at 33.89M.
A.I. Advisor
published General Information

General Information

a development stage company, which focuses on treatment of diabetes

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
20271 Goldenrod Lane
Phone
+1 480 659-6404
Employees
167
Web
https://www.orgenesis.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
MVBF22.910.47
+2.09%
MVB Financial Corp
VYNE2.250.02
+0.90%
VYNE Therapeutics
AGRO9.69-0.08
-0.82%
Adecoagro SA
CMI295.10-4.33
-1.45%
Cummins
TPG46.91-0.84
-1.76%
TPG

ORGS and Stocks

Correlation & Price change

A.I.dvisor tells us that ORGS and LOGC have been poorly correlated (+29% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that ORGS and LOGC's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ORGS
1D Price
Change %
ORGS100%
+2.54%
LOGC - ORGS
29%
Poorly correlated
-1.29%
FATE - ORGS
27%
Poorly correlated
-1.98%
IRON - ORGS
25%
Poorly correlated
-0.52%
CRBU - ORGS
24%
Poorly correlated
-3.30%
AXON - ORGS
24%
Poorly correlated
-0.52%
More